Fakultätsinterviews


 
Practical Approaches to the Genetic Diagnosis and Management of Patients with Diabetes Mellitus
 
47
In what patients is genetic testing for diabetes mellitus recommended?
136
What are the benefits that a genetic diagnosis of diabetes mellitus can offer?
283
What implications does a genetic diagnosis of diabetes mellitus have on management?
 
Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
 
45
What are some of the most relevant updates in the new guidelines compared to the previous version?
203
Why were these updates added?
480
How can personalized medicine play a role in prevention strategies?
 
The Impact of COVID-19 on Endocrinology
 
73
Are patients with diabetes at higher risk of complications from COVID-19?
390
What do we know about control of diabetes and the severity of the disease?
553
What practical tips can you give to healthcare providers managing patients with endocrine diseases in light of the COVID-19 pandemic?
 
Type 1 Diabetes Mellitus - From Preconception to Postpartum
 
48
What are some of the most common misconceptions regarding pregnancy and type 1 diabetes?
125
How important is planning pregnancy in type 1 diabetes?
194
How do insulin requirements change during pregnancy and postpartum?
305
Are there any particular types of insulins to prefer during pregnancy?
376
Do technologies such as CGM help during pregnancy?
 
More Than A1c: Important Outcomes for Those with Diabetes
 
54
How can successful outcomes be defined in people with diabetes?
151
Will the use of A1c become obsolete as technologies such as CGM become available?
233
What metrics are used to measure time-in-range and glucose variability?
369
Are technologies such as CGM applicable to both T1D and T2D?
484
What are some of the barriers to the use of CGM?
 
Beta Cells in Type 1 Diabetes – Sleeping or Dead?
 
39
What new insights are being discovered regarding the role of beta cells in type 1 diabetes?
230
What therapies are being investigated that target beta cells in patients with type 1 diabetes?
407
How far are we from using therapies that target dysfunctional beta cells in clinical practice?